{"id":"W2806039308","doi":"10.1016/j.clml.2018.05.022","title":"An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Gastroenterology; Peripheral edema; Anemia; Hypoalbuminemia; Adverse effect; Leukopenia; Hyponatremia; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407813,0.001571388,0.001460214,0.0003101891,0.0003532114,0.0008930461,0.0009524422,0.001156098,0.003989026],"category_scores_gemma":[0.0007375919,0.0004401808,0.0007666715,0.0003281081,0.0009605487,0.0009531103,0.000306138,0.002740773,0.0009738852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008737805,"about_ca_system_score_gemma":0.001169653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008044361,"about_ca_topic_score_gemma":0.002473907,"domain_scores_codex":[0.9996096,0.000199562,0.00001906213,0.0000697442,0.00003457511,0.00006739203],"domain_scores_gemma":[0.9993437,0.0001204946,0.0001248221,0.00005165998,0.00004369649,0.0003155444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8468474,0.06084846,0.003564799,0.0007706519,0.001124522,0.0003124444,0.0002448887,0.001524083,0.02710067,0.0002096575,0.002525284,0.05492716],"study_design_scores_gemma":[0.7433494,0.245575,0.006381615,0.0000240959,0.0002523489,0.000243906,0.00005829331,0.0009709481,0.001793125,0.0001182816,0.001215993,0.00001688932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950901,0.001316352,0.0004002468,0.0002261304,0.00008318682,0.001158776,0.0006090827,0.00005425339,0.001061763],"genre_scores_gemma":[0.9936885,0.0009944832,0.0007895933,0.00047703,0.000127989,0.001057123,0.00157826,0.00001618276,0.001270943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003989026,"threshold_uncertainty_score":0.01334459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0460260974443202,"score_gpt":0.3835334315622945,"score_spread":0.3375073341179743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}